Purpose: To evaluate the effectiveness and the systemic corticosteroid sparing effect of a
single intravitreal dexamethasone (DEX) implant in patients with chronic noninfectious …

Purpose: To assess safety and efficacy of intravitreal dexamethasone (DEX) implant in
refractory uveitic macular edema (ME). Methods: We retrospectively analyzed medical …

Purpose: To report observations on the single and repeat use of the dexamethasone (DEX)
intravitreal implant (Ozurdex; Allergan, Inc, Irvine, CA) for the treatment of macular edema in …

Purpose To examine the observational effectiveness of the dexamethasone (DEX)
intravitreal implant (Ozurdex; Allergan, Inc., Irvine, CA) in the treatment of noninfectious …

Purpose The purpose of this study was to report the functional and anatomical outcomes of a
prospective study resulting from repeated dexamethasone intravitreal implants in patients …

Macular edema (ME) is a common cause of visual loss among eyes with uveitis, and its
management can be challenging. Steroids are an effective treatment for ME, and intravitreal …

Background Uveitic macular edema is a complication of acute or chronic uveitis. Current
treatment regiments frequently have numerous side effects, often requiring supplemental …

Purpose: To describe the clinical outcome of phakic eyes with macular edema (ME) due to
non-infectious uveitis treated with a dexamethasone intravitreal implant. Methods: A …

Purpose: To report the long-term outcome of an intravitreal dexamethasone drug delivery
system (DEX-DDS) injection for noninfectious uveitic macular edema. Methods: This was a …

Purpose: To investigate the effect of a single intravitreal dexamethasone implant (IVT-DI;
Ozurdex; Allergan, Inc.) on visual acuity, macular thickness, and intraocular pressure (IOP) …